BioCryst Pharmaceuticals (NASDAQ: BCRX) is a biopharmaceutical company that discovers and develops oral, small-molecule drugs targeting rare diseases. The filing excerpts provided do not contain sufficient detail to describe its revenue model, product portfolio, customer base, geographic footprint, competitive position, or financial metrics with the specificity required. Based solely on the available filing excerpt, no further supported claims can be made about BioCryst's business operations, revenue streams, or market position.

Source: SEC 10-K, filed 2026-02-26

Industry: Biological Products, (No Diagnostic Substances) Peers: ACADIA Pharmaceuticals Inc Fate Therapeutics Inc Insmed Inc Prometheus Biosciences, Inc. Relay Therapeutics Inc Sage Therapeutics, Inc. Prokidney Corp Ultragenyx Pharmaceutical Inc Vir Biotechnology Inc